ARTICLE SUMMARY:
Ed Shenkan, a veteran medical device deals and investments consultant, recently joined FDA’s device center as associate director of the TPLC Advisory Program. Shenkan will oversee day-to-day operations for the TAP pilot, which CDRH has billed as an innovative early-interaction approach allowing firms to gauge regulatory, reimbursement, and other market risks early in a development project.
Ed Shenkan, a longtime medtech deals expert and market analyst, has joined FDA’s device center to run CDRH’s newly launched TPLC Advisory Program (TAP) pilot.
“Ed brings to CDRH a wealth of medical device, business and management experience, where his leadership and capabilities will bring exciting vision to the TAP Pilot,” according to an FDA spokesperson, who confirmed the hiring to Market Pathways.
